Verition Fund Management LLC Madrigal Pharmaceuticals, Inc. Transaction History
Verition Fund Management LLC
- $19.9 Billion
- Q1 2025
A detailed history of Verition Fund Management LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 4,024 shares of MDGL stock, worth $1.29 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,024
Previous 4,000
0.6%
Holding current value
$1.29 Million
Previous $1.23 Million
7.94%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding MDGL
# of Institutions
365Shares Held
23.2MCall Options Held
979KPut Options Held
459K-
Janus Henderson Group PLC London, X02.21MShares$706 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$672 Million39.89% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$647 Million10.84% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$638 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$632 Million7.8% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.47B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...